Search

Author/Creator Mugnier, Pierre

1. First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects. (5th March 2018)

Authors:
Perera, Vidya; Luettgen, Joseph M.; Wang, Zhaoqing; Frost, Charles E.; Yones, Cynthia; Russo, Cesare; Lee, John; Zhao, Yue; LaCreta, Frank P.; Ma, Xuewen; Knabb, Robert M.; Seiffert, Dietmar; DeSouza, Mary; Mugnier, Pierre; Cirincione, Brenda; Ueno, Takayo; Frost, Robert J. A.
Journal:
British journal of clinical pharmacology
Issue:
Volume 84:Number 5(2018:Nov.)
Page Start:
876
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank. Issue 4 (10th February 2018)

Authors:
Torok, Rachel D.; Li, Jennifer S.; Kannankeril, Prince J.; Atz, Andrew M.; Bishai, Raafat; Bolotin, Ellen; Breitenstein, Stefanie; Chen, Cathy; Diacovo, Thomas; Feltes, Timothy; Furlong, Patricia; Hanna, Michael; Graham, Eric M.; Hsu, Daphne; Ivy, D. Dunbar; Murphy, Dianne; Kammerman, Lisa A.; Ke...
Journal:
Journal of the American Heart Association
Issue:
Volume 7:Issue 4(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗